Because CPT and Eto are known to promote NF-κB-dependent apoptosis resistance, USP47 inhibition may be a suitable strategy to overcome drug resistance induces by NF-κB signaling pathway in gastric cancer (Naghavi et al., 2018). Here, NFKB1 is linked to gastric cancer.